<?xml version="1.0" encoding="UTF-8"?>
<p id="p0295">Corticosteroids can be useful in controlling CRS, for instance in cancer immunotherapy. Initially, dexamethasone was proposed as an effective agent for managing CRS. However, due to the enhanced risk of vascular necrosis and diabetes (which are mortality risk factors for COVID-19), corticosteroid administration for COVID-19 patients is not recommended 
 <xref rid="b0615" ref-type="bibr">[123]</xref>.
</p>
